Clinical trial · Observational
To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
To Assess the Impact of the Enhanced Recovery After Surgery (ERAS) Consensus on the Effectiveness and Prognosis of Patients With Endoscopic Pituitary Tumor Surgery
NCT06221020CI-TRIAL-00122219recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Enhanced Recovery After Surgery | — | UNRESOLVED | — |
| Pituitary Tumor | Pituitary Gland Neoplasm | ALIAS | 0.90 |
| Postoperative Complications | — | UNRESOLVED | — |
Interventions
Interventions (9)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Apfel Score for Postoperative nausea and vomiting | Diagnostic Test | — | UNRESOLVED |
| BDI-II(Beck Depression Inventory-II) | Behavioral | — | UNRESOLVED |
| ERAS Patient Satisfaction Questionnaire(ERAS-PSQ) | Behavioral | — | UNRESOLVED |
| Malnutrition Universal Screening Tool | Diagnostic Test | — | UNRESOLVED |
| Quality of Recovery-40(QoR-40) | Behavioral | — | UNRESOLVED |
| Short Form-36 | Behavioral | — | UNRESOLVED |
| The American Society of Anesthesiologists (ASA) Physical Status Classification | Diagnostic Test | — | UNRESOLVED |
| TIB Olfactory Test Device |
Design
Arms and outcomes
Arms (2)
- label
- Patients with ERAS
- description
- In the experimental group (Patients with ERAS), participants will undergo an assessment of the Enhanced Recovery After Surgery (ERAS) consensus items. The experimental group will complete all the items on the ERAS forms as far as possible. All groups will undergo our routine preoperative evaluation for pituitary tumor surgery, such as cardiopulmonary function, hormone testing, vision and visual field examination, etc. The care during hospitalization and surgery will be the same as previously for patients with pituitary tumors, and the post-discharge outpatient follow-up will also be the same as for patients who have undergone pituitary tumor surgery.
- interventionNames
- Diagnostic Test: Malnutrition Universal Screening Tool
- Device: TIB Olfactory Test Device
- Diagnostic Test: Apfel Score for Postoperative nausea and vomiting
- Diagnostic Test: The American Society of Anesthesiologists (ASA) Physical Status Classification
- Behavioral: Short Form-36
- Behavioral: World Health Organization Quality of Life questionnaire (WHOQOL-BREF)
- Behavioral: BDI-II(Beck Depression Inventory-II)
- Behavioral: ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)
- Behavioral: Quality of Recovery-40(QoR-40)
- label
- Patients with Regular
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of pituitary tumors * To sign a written informed consent form Exclusion Criteria: * Diagnosed with other malignant tumors * Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area * Pregnant women * Coagulation disorders or those taking anticoagulant medication * Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment * Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment
References
Publications (0)
Data not yet available
No reference posted for this study.